Skip to main content
HSIC
NASDAQ Trade & Services

Henry Schein Beats on Q3 EPS and Raises FY2026 Guidance to $5.50-$5.56

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
7
Price
$82
Mkt Cap
$9.653B
52W Low
$62.44
52W High
$92.18
52W Position info
31% above low
Off High info
11% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

HSIC sits 31% above its 52-week low of $62.44 on elevated volume (2.2× avg).

Summary

Henry Schein reported Q3 non-GAAP EPS of $1.56 (up 13.0%) and raised FY2026 non-GAAP EPS guidance to $5.50-$5.56, helped by a $0.19 per share tariff refund benefit and 8.6% U.S. dental merchandise growth.


Key Events · Earnings and Guidance · HSIC

  • Q3 EPS Beats, Guidance Raised

    Q3 non-GAAP diluted EPS was $1.56, up 13.0% year over year, and FY2026 non-GAAP EPS guidance rose to $5.50-$5.56 from $5.29-$5.39.

  • Underlying Growth 19.1% Ex-Items

    Excluding $0.19 per share of net tariff refunds and prior-year remeasurement gains, non-GAAP EPS was $1.37 versus $1.15, up 19.1%; Q3 sales were $3.47 billion, up 4.0%.

  • U.S. Dental Merchandise Up 8.6%

    U.S. dental merchandise sales grew 8.6% on volume and market-share gains in a stable market; total internal sales growth was 3.1%.

  • Buyback Continues at $125M

    The company repurchased about 1.4 million shares at an average of $86.67 for $125 million in Q3, leaving roughly $330 million authorized for future repurchases.


Analysis · HSIC · Trade & Services

Henry Schein's Q3 came in ahead of the prior outlook, and management lifted full-year non-GAAP EPS guidance to $5.50-$5.56 from $5.29-$5.39, with Adjusted EBITDA growth now expected in the high-single-digits. The beat is broad-based: U.S. dental merchandise sales rose 8.6% on volume and market-share gains, and non-GAAP EPS of $1.37 excluding tariff refunds was up 19.1% year over year. Part of the raise is one-time in nature — a $0.19 per share net tariff refund benefit booked in Q3 — so the underlying improvement is smaller than the headline guidance bump suggests. The company also kept buying back stock, repurchasing 1.4 million shares for $125 million in the quarter at an average of $86.67, above today's $82 price, leaving $330 million authorized.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HSIC was trading at $82.00 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $9.7B. The 52-week trading range was $62.44 to $92.18. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HSIC - Latest Insights

HSIC
Nov 16, 2026, 6:01 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $86.22
Real-time Price: $84.47 info
Change: -$1.75 (-2%) info
Market Cap: $9.344B info
HSIC
Nov 03, 2026, 3:24 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $82.82
Real-time Price: $84.47 info
Change: +$1.65 (+2%) info
Market Cap: $9.344B info
HSIC
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $86.50
Real-time Price: $84.47 info
Change: -$2.03 (-2%) info
Market Cap: $9.344B info
HSIC
Oct 08, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $84.30
Real-time Price: $84.47 info
Change: +$0.170 (+0.20%) info
Market Cap: $9.344B info
HSIC
Aug 04, 2026, 11:58 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $87.73
Real-time Price: $84.47 info
Change: -$3.25 (-4%) info
Market Cap: $9.344B info